NCT02813252View on ClinicalTrials.gov

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

October 22, 2021

Study Completion Date

October 22, 2021

Conditions
Acute Lymphoblastic Leukemia
Interventions
GENETIC

JCAR015

No study drug is administered in this study. Patients who received JCAR015 in a previous trial will be evaluated in this trial for long-term safety and efficacy.

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

21231

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

60611

Northwestern University, Chicago

63110-1093

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Juno Therapeutics, a Subsidiary of Celgene

INDUSTRY

NCT02813252 - Long-Term Follow-up Study for Patients Previously Treated With JCAR015 | Biotech Hunter | Biotech Hunter